Home » Medical Devices » Blood Management Software Market

Blood Management Software Market By Type / Module (Donation (Donor) Management, Transfusion Service, Blood Collection & Processing, Inventory Management, Patient Blood Management, Compliance / Quality Assurance, Analytics / Decision Support); By Deployment (On-premise, Cloud / SaaS, Hybrid); By Application (Blood Donor Management, Blood Bank Management, Transfusion Management, Patient Blood Management); By Functionality (Inventory Management, Reporting & Analytics, Compliance Management, Data Management); By End User (Hospitals, Stand-alone Blood Banks, Plasma & Apheresis Centers, Public Health / Red-Cross Agencies, Blood Donation Centers, Diagnostic Laboratories, Research Institutions); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Report ID: 203514 | Report Format : Excel, PDF

Blood Management Software Market Overview:

The global Blood Management Software market size was estimated at USD 1242.37 million in 2025 and is expected to reach USD 2219.12 million by 2032, growing at a CAGR of 8.64% from 2025 to 2032. Growth is primarily driven by the rising need to digitize end-to-end blood workflows across donor recruitment, collection, testing, storage, issue, and bedside transfusion verification to reduce errors and improve traceability. Healthcare providers are prioritizing modern platforms that strengthen compliance readiness, improve inventory visibility, and support faster decision-making during shortages and demand surges.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Blood Management Software Market Size 2025 USD 1242.37 million
Blood Management Software Market, CAGR 8.64%
Blood Management Software Market Size 2032 USD 2219.12 million

 

Key Market Trends & Insights

  • Cloud / SaaS held a 51% share in 2025, driven by faster implementation timelines, centralized upgrades, and scalable architecture suited to multi-site health systems.
  • Donation (Donor) management captured a 37% share in 2025, as blood centers and hospitals strengthened donor scheduling, eligibility verification, and digitized records to stabilize collections.
  • Hospitals accounted for a 48% share in 2025, supported by demand for controlled transfusion workflows, accurate patient identification, and integration with broader clinical IT systems.
  • North America represented a 38.10% share in 2025, supported by mature health IT adoption, strict regulatory compliance requirements, and stronger institutional purchasing capacity.
  • Asia Pacific is expected to grow strongly during 2026–2032, supported by blood service modernization efforts and expanding digital infrastructure across the region.

Blood Management Software Market Size

Segment Analysis

Blood Management Software Market demand is shaped by the need to improve safety, efficiency, and auditability across the transfusion chain, from donor intake to patient administration. Buyers increasingly prioritize integrated platforms that unify donor management, laboratory workflows, labeling, inventory tracking, and transfusion documentation to reduce manual handoffs and minimize preventable mismatches. Operational analytics is gaining importance as providers seek better forecasting for short-dated products, improved allocation decisions, and faster visibility into usage patterns across departments and sites.

Adoption is also supported by shifts in procurement toward software models that reduce upfront infrastructure burden and simplify upgrades. Hospitals and blood centers are moving toward systems that enable standardized reporting, role-based workflows, and consistent compliance outputs across multiple facilities. At the same time, demand is rising for features that strengthen governance, such as electronic audit trails, exception management, barcode-enabled traceability, and quality controls aligned with evolving regulatory expectations.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

 

By Type / Module Insights

Donation (Donor) management accounted for the largest share of 37% in 2025. Donation management leads because stable donor engagement, eligibility documentation, and appointment coordination directly influence supply continuity and collection productivity. Providers also adopt donor-centric modules to consolidate donor histories, improve communications, and reduce manual errors in intake workflows. Digital donor pipelines further support downstream traceability by improving data quality before collection and testing activities begin.

By Deployment Insights

Cloud / SaaS accounted for the largest share of 51% in 2025. Cloud deployments lead due to faster implementation timelines, simplified upgrades, and the ability to support distributed operating models across hospital networks and collection sites. Organizations also value centralized security controls, disaster recovery features, and improved accessibility for authorized staff. Cloud-native releases commonly enable quicker rollout of analytics, dashboards, and integration enhancements that improve operational decision-making.

By Application Insights

Blood bank management, transfusion management, donor management, and patient blood management applications are being deployed to improve control across critical workflows and reduce fragmentation between collection, laboratory, and clinical administration. Adoption is strongest where organizations have complex, multi-step processes that require standardized documentation and timely coordination between teams. Providers increasingly select platforms that can unify workflow steps and reduce reconciliation delays between inventory, testing results, and clinical ordering. Integration readiness with laboratory systems and hospital information systems remains a key selection factor for application-layer deployments.

By Functionality Insights

Inventory management, reporting and analytics, compliance management, and data management functionalities are increasingly being bundled to support end-to-end governance and performance visibility. Inventory controls remain central due to short shelf-life constraints and the need to reduce waste while maintaining service levels. Reporting and analytics functionality is expanding as organizations seek better forecasting, utilization benchmarking, and shortage response planning. Compliance and data management capabilities are prioritized to maintain traceability, standardize documentation, and support audit-readiness across sites and departments.

By End User Insights

Hospitals accounted for the largest share of 48% in 2025. Hospitals lead adoption because transfusion workflows require tight controls over patient identification, product verification, and reaction reporting within time-sensitive clinical environments. Hospitals also manage higher procedure volumes and broader care pathways, creating stronger demand for integrated documentation, traceability, and inventory visibility at the point of care. Multi-site hospital systems further drive demand for standardization, centralized reporting, and consistent compliance outputs across facilities.

Market Drivers

Increasing focus on transfusion safety and traceability

Blood Management Software Market growth is supported by sustained emphasis on transfusion safety, product traceability, and reduction of preventable errors. Digital workflows help standardize verification steps, strengthen patient identification practices, and improve documentation consistency across departments. Automated tracking and audit trails reduce reliance on manual logs and support faster issue resolution. These capabilities are particularly important in high-volume settings where workflow complexity increases risk exposure.

Rising need for inventory optimization and waste reduction

Short shelf-life constraints and variability in supply and demand increase the need for better inventory visibility and allocation controls. Software platforms support real-time stock tracking, expiry management, and redistribution planning across sites to reduce wastage. Forecasting tools and utilization insights improve planning for seasonal demand swings and emergency scenarios. These outcomes directly support cost control objectives and service-level reliability.

  • For instance, Haemonetics positions BloodTrack OnDemand (with HaemoBank) as enabling a “virtual 24/7 automated transfusion service,” aligning with hospitals’ need to keep inventory controlled at the point of care while reducing over-allocation behaviors that contribute to expiry-related waste.

Digital transformation of blood centers and hospital operations

Healthcare providers and blood services are accelerating digitization initiatives to replace fragmented or legacy processes with unified platforms. Standardized workflows improve coordination across donor, collection, laboratory, and clinical administration stages. Digitization also improves reporting consistency, enabling easier governance across multi-site organizations. As digital maturity increases, buyers seek platforms that provide scalability and integration readiness.

Strengthening compliance and quality management requirements

Organizations face ongoing pressure to maintain audit-ready documentation and consistent quality practices across locations and teams. Software solutions support standardized operating procedures through controlled workflows, electronic records, and exception management. Compliance-focused features reduce administrative burden while improving completeness and consistency of records. This driver supports upgrades from older systems that do not meet evolving operational and governance expectations.

  • For instance, Haemonetics notes BloodTrack Tx is FDA 510(k)-cleared and electronically records transfusions (including patient vitals, reactions, and staff IDs) to support hemovigilance documentation, and it explicitly maps traceability/recordkeeping support to numbered requirements such as AABB 5.1.6.2 and FDA 606.160(a)(1) for audit alignment.

Market Challenges

Implementation complexity remains a major challenge, particularly where blood workflows span multiple departments and facilities with different operating practices. Integrating software with laboratory systems, hospital information systems, and bedside verification workflows can require careful change management and process redesign. Data migration from legacy systems may introduce delays due to record quality issues and the need for validation. Training requirements can be significant because safety-critical steps must be executed consistently across clinical and operational teams.

  • For instance, a UK three-hospital implementation of Haemonetics’ BloodTrack electronic blood management approach reported “wrong blood in tube” events of 1/12,322 samples pre-implementation versus 1/26,690 samples post-implementation, alongside sample rejection rates of 1,004/31,406 (3.2%) versus 541/44,373 (1.2%),

Budget constraints and procurement cycles also slow adoption, especially for smaller blood centers and resource-constrained health systems. Buyers must balance software investment against competing priorities, which can defer upgrades even when operational needs are clear. Cybersecurity considerations add complexity, as organizations require robust controls for sensitive clinical and donor information. Vendor selection risk increases when long-term support, upgrade pathways, and integration capabilities are not clearly aligned with organizational needs.

Market Trends and Opportunities

Cloud adoption is expanding as organizations aim to reduce infrastructure burden and accelerate deployment across multi-site operating models. Demand is also increasing for platforms that combine workflow automation with analytics to support forecasting, utilization benchmarking, and shortage response planning. Buyers are prioritizing solutions that strengthen interoperability, enabling more seamless coordination between blood bank operations and clinical ordering workflows. These trends support platform consolidation and higher adoption of standardized enterprise deployments.

Opportunities are emerging in advanced analytics and decision support that can improve stock planning and reduce wastage without compromising availability. Expanding digitization programs across developing healthcare systems create growth potential for configurable platforms that can be implemented in phased rollouts. Vendors that provide strong implementation support, integration tooling, and role-based workflow controls can differentiate in competitive tenders. Increasing focus on patient blood management programs also supports demand for software that connects clinical protocols with utilization reporting and governance.

  • For instance, MAK-SYSTEM and Héma-Québec reported a successful implementation of ePROGESA to run Héma-Québec’s end-to-end blood operations, noting Héma-Québec collects more than 300,000 units of blood each year and needs a minimum of 1,000 new donations daily to maintain adequate inventory; MAK-SYSTEM also stated the solution has been deployed in over 60 countries.

Regional Insights

North America

North America leads market adoption due to mature healthcare IT ecosystems and strong emphasis on transfusion governance. The region accounted for 38.10% share in 2025, supported by higher institutional spending capacity and standardized operational frameworks across large hospital networks. Health systems in the region prioritize integration across laboratory and clinical workflows to strengthen verification and documentation. Adoption is also supported by broad demand for analytics-driven inventory optimization and compliance-ready reporting.

Europe

Europe accounted for 26.73% share in 2025, supported by established hospital networks and ongoing modernization of blood service operations. Buyers in the region prioritize standardized documentation, traceability, and consistent quality controls across multi-site environments. Procurement often favors solutions with strong interoperability and validated workflow controls aligned with institutional governance. Demand is further supported by efforts to reduce wastage and improve cross-facility coordination.

Asia Pacific

Asia Pacific represented 23.14% share in 2025 and is expanding rapidly as digitization and modernization programs accelerate across healthcare systems. Regional growth is supported by expanding hospital capacity, increasing focus on safety, and broader rollout of digital infrastructure. Organizations are prioritizing scalable platforms that can support distributed collection and transfusion environments. Stronger analytics and decision support adoption is also increasing as stakeholders focus on supply reliability and improved planning.

Latin America

Latin America accounted for 7.09% share in 2025, with growth supported by gradual modernization of blood services and hospital operations. Adoption is strongest in larger institutions and urban health systems where workflow complexity and audit needs are higher. Buyers prioritize solutions that improve traceability and inventory controls while remaining feasible within budget constraints. Implementation support and integration capabilities remain important differentiators for vendor selection.

Middle East & Africa

Middle East & Africa held 4.94% share in 2025, with adoption driven by expanding healthcare infrastructure and increasing focus on operational standardization. Growth is supported by investments in hospital networks and centralized blood services in selected markets. Buyers often prioritize systems that improve documentation consistency, compliance readiness, and stock visibility across sites. Vendor support, training, and deployment flexibility influence adoption outcomes across diverse operating environments.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Competitive Landscape

Competition in the Blood Management Software Market is shaped by the ability to deliver end-to-end workflow coverage, reliable interoperability, and audit-ready traceability across donor, laboratory, inventory, and transfusion pathways. Vendors differentiate through integration depth with clinical and laboratory systems, configurable workflow controls, and implementation support capabilities for complex multi-site environments. Product roadmaps increasingly emphasize analytics, real-time visibility, and decision support to improve planning and reduce wastage. Cloud-ready architectures and security controls are also key differentiators as buyers prioritize scalability and governance.

Veradigm’s positioning is supported by a broader healthcare software footprint that can align blood management workflows with adjacent clinical and administrative processes. The company’s approach is typically centered on enabling structured data capture, workflow consistency, and integration readiness to support operational reporting and governance needs. As buyers seek consolidation and stronger interoperability, platform vendors that can support standardized enterprise deployments remain well-positioned. Execution quality in implementation support and ongoing upgrades remains critical for sustaining competitive advantage.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Veradigm
  • WellSky
  • Haemonetics
  • Oracle (Integrating Cerner Corporation)
  • Epic Systems
  • Soft Computer Consultants (SCC Soft Computer)
  • MAK-System
  • McKesson
  • Sunquest Information Systems
  • Mediware Information Systems
  • CompuGroup Medical
  • IT Synergistics
  • Hemosoft
  • Sigma Blood Systems

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Recent Developments

  • ​ In September 2025, Blood Bank Computer Systems, Inc. (BBCS) announced a partnership with Blood Assurance to serve as its blood establishment computer system (BECS) provider and implement the ForLife Biologics Platform™. In the announcement, the organizations positioned the ForLife Biologics Platform™ implementation as a way to strengthen operations and enhance the donor experience across Blood Assurance’s regional network.
  • In November 2024, Blood Bank Computer Systems, Inc. (BBCS) announced that Coastal Bend Blood Center (CBBC) became the first organization to implement the ForLife™ Biologics Platform along with Blood Bank Control System 6.1. In the same release, BBCS described the implementation as a milestone aimed at streamlining end-to-end blood center operations (from donor/product monitoring and testing through distribution).
  • ​In November 2024, the international Macopharma group (GMPi) announced an acquisition of Germany-based Lmb Technologie in the blood sector. In its acquisition note, Macopharma specifically referenced strengthening its end-to-end offering by combining blood kits/filtration, equipment technology, and data management software alongside service expertise to better meet blood bank needs.
  • In October, 2024, BBCS leadership publicly stated that the ForLife™ Biologics Platform and Blood Bank Control System 6.0 were “live in production,” highlighting Coastal Bend Blood Center as the implementation site. In that update, the go-live was framed as a notable operational milestone for the platform in real-world blood center usage.

Report Scope

Report Attribute Details
Market size value in 2025 USD 1242.37 million
Revenue forecast in 2032 USD 2219.12 million
Growth rate (CAGR) 8.64% (2025–2032)
Base year 2025
Forecast period 2026–2032
Quantitative units USD million
Segments covered By Type / Module Outlook: Donation (Donor) management, Transfusion service, Blood collection & processing, Inventory management, Patient blood management, Compliance / Quality assurance, Analytics / Decision support; By Deployment Outlook: On-premise, Cloud / SaaS, Hybrid; By Application Outlook: Blood donor management, Blood bank management, Transfusion management, Patient blood management; By Functionality Outlook: Inventory management, Reporting & analytics, Compliance management, Data management; By End User Outlook: Hospitals, Stand-alone blood banks, Plasma & apheresis centers, Public health / Red-Cross agencies, Blood donation centers, Diagnostic laboratories, Research institutions
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies profiled Veradigm, WellSky, Haemonetics, Oracle (Integrating Cerner Corporation), Epic Systems, Soft Computer Consultants (SCC Soft Computer), MAK-System, McKesson, Sunquest Information Systems, Mediware Information Systems, CompuGroup Medical, IT Synergistics, Hemosoft, Sigma Blood Systems
No. of Pages 340

Segmentation

BY TYPE / MODULE

  • Donation (Donor) management
  • Transfusion service
  • Blood collection & processing
  • Inventory management
  • Patient blood management
  • Compliance / Quality assurance
  • Analytics / Decision support

BY DEPLOYMENT

  • On-premise
  • Cloud / SaaS
  • Hybrid

BY APPLICATION

  • Blood donor management
  • Blood bank management
  • Transfusion management
  • Patient blood management

BY FUNCTIONALITY

  • Inventory management
  • Reporting & analytics
  • Compliance management
  • Data management

BY END USER

  • Hospitals
  • Stand-alone blood banks
  • Plasma & apheresis centers
  • Public health / Red-Cross agencies
  • Blood donation centers
  • Diagnostic laboratories
  • Research institutions

BY REGION

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Table of Contents

  1. Introduction
    1. Report Description
    1.2. Objectives of the Study
    1.3. Market Scope
    1.4. Target Audience
    1.5. Assumptions & Limitations
  2. Research Methodology
    1. Research Design and Approach
    2.2. Data Sources
    2.2.1. Primary Research
    2.2.2. Secondary Research
    2.3. Market Size Estimation
    2.3.1. Top-Down Approach
    2.3.2. Bottom-Up Approach
    2.4. Forecasting Methodology
    2.5. Data Validation & Triangulation
  3. Executive Summary
  4. Market Overview
    1. Blood Management Software: Overview and Scope
    4.2. Workflow Coverage (donor → collection/processing → inventory → transfusion → patient blood management)
    4.3. Market Dynamics
    4.3.1. Drivers
    4.3.2. Restraints
    4.3.3. Opportunities
    4.3.4. Challenges
    4.4. Key Trends (digitization, interoperability, cloud adoption, analytics/AI, traceability)
    4.5. Regulatory, Compliance & Data Privacy Landscape
  5. Global Blood Management Software Market
    1. Market Size & Forecast
    5.2. Market Share Analysis
    5.3. Pricing and Licensing Models (subscription, perpetual, usage-based)
    5.4. Integration Landscape (LIS/HIS/EMR, lab instruments, e-prescribing—context)
  6. Market Segmentation: By Type / Module
    1. Donation (Donor) Management
    6.1.1. Overview
    6.1.2. Market Trends
    6.1.3. Market Size & Forecast

6.2. Transfusion Service
6.2.1. Overview
6.2.2. Market Trends
6.2.3. Market Size & Forecast

6.3. Blood Collection & Processing
6.3.1. Overview
6.3.2. Market Trends
6.3.3. Market Size & Forecast

6.4. Inventory Management
6.4.1. Overview
6.4.2. Market Trends
6.4.3. Market Size & Forecast

6.5. Patient Blood Management
6.5.1. Overview
6.5.2. Market Trends
6.5.3. Market Size & Forecast

6.6. Compliance / Quality Assurance
6.6.1. Overview
6.6.2. Market Trends
6.6.3. Market Size & Forecast

6.7. Analytics / Decision Support
6.7.1. Overview
6.7.2. Market Trends
6.7.3. Market Size & Forecast

  1. Market Segmentation: By Deployment
    1. On-Premise
    7.1.1. Market Trends
    7.1.2. Market Size & Forecast

7.2. Cloud / SaaS
7.2.1. Market Trends
7.2.2. Market Size & Forecast

7.3. Hybrid
7.3.1. Market Trends
7.3.2. Market Size & Forecast

  1. Market Segmentation: By Application
    1. Blood Donor Management
    8.1.1. Market Trends
    8.1.2. Market Size & Forecast

8.2. Blood Bank Management
8.2.1. Market Trends
8.2.2. Market Size & Forecast

8.3. Transfusion Management
8.3.1. Market Trends
8.3.2. Market Size & Forecast

8.4. Patient Blood Management
8.4.1. Market Trends
8.4.2. Market Size & Forecast

  1. Market Segmentation: By Functionality
    1. Inventory Management
    9.1.1. Market Trends
    9.1.2. Market Size & Forecast

9.2. Reporting & Analytics
9.2.1. Market Trends
9.2.2. Market Size & Forecast

9.3. Compliance Management
9.3.1. Market Trends
9.3.2. Market Size & Forecast

9.4. Data Management
9.4.1. Market Trends
9.4.2. Market Size & Forecast

  1. Market Segmentation: By End User
    1. Hospitals
    10.1.1. Market Trends
    10.1.2. Market Size & Forecast

10.2. Stand-alone Blood Banks
10.2.1. Market Trends
10.2.2. Market Size & Forecast

10.3. Plasma & Apheresis Centers
10.3.1. Market Trends
10.3.2. Market Size & Forecast

10.4. Public Health / Red-Cross Agencies
10.4.1. Market Trends
10.4.2. Market Size & Forecast

10.5. Blood Donation Centers
10.5.1. Market Trends
10.5.2. Market Size & Forecast

10.6. Diagnostic Laboratories
10.6.1. Market Trends
10.6.2. Market Size & Forecast

10.7. Research Institutions
10.7.1. Market Trends
10.7.2. Market Size & Forecast

  1. Market Breakup by Region
    1. North America
    11.2. Europe
    11.3. Asia Pacific
    11.4. Latin America
    11.5. Middle East & Africa
  2. Competitive Landscape
    1. Market Structure and Competitive Overview
    12.2. Competitive Benchmarking (modules, interoperability, deployment, security, support)
    12.3. Strategic Developments (partnerships, product upgrades, M&A, integrations)

12.4. Company Profiles
12.4.1. Veradigm
12.4.2. WellSky
12.4.3. Haemonetics
12.4.4. Oracle (Integrating Cerner Corporation)
12.4.5. Epic Systems
12.4.6. Soft Computer Consultants (SCC Soft Computer)
12.4.7. MAK-System
12.4.8. McKesson
12.4.9. Sunquest Information Systems
12.4.10. Mediware Information Systems
12.4.11. CompuGroup Medical
12.4.12. IT Synergistics
12.4.13. Hemosoft
12.4.14. Sigma Blood Systems

  1. Porter’s Five Forces Analysis
    1. Overview
    13.2. Bargaining Power of Suppliers
    13.3. Bargaining Power of Buyers
    13.4. Threat of New Entrants
    13.5. Threat of Substitutes
    13.6. Competitive Rivalry
  2. SWOT Analysis
    1. Overview
    14.2. Strengths
    14.3. Weaknesses
    14.4. Opportunities
    14.5. Threats
  3. Market Opportunities and Future Outlook
    1. Opportunities by Module and End User
    15.2. Innovation Outlook (cloud modernization, interoperability, analytics/AI, cybersecurity)
    15.3. Future Market Outlook
  4. Appendix
    1. Abbreviations
    16.2. List of Tables & Figures
    16.3. Disclaimer
Request Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices


Providing the strategic compass for industry titans.

cr-clients-logos

Frequently Asked Questions:

What is the market size of the Blood Management Software Market in 2025 and what is the forecast for 2032?

The Blood Management Software Market was valued at USD 1242.37 million in 2025 and is projected to reach USD 2219.12 million by 2032.

What is the CAGR for the Blood Management Software Market during 2025–2032?

The Blood Management Software Market is expected to grow at a CAGR of 8.64% during 2025–2032.

The Blood Management Software Market is expected to grow at a CAGR of 8.64% during 2025–2032.

Donation (Donor) management is the largest type/module segment, accounting for 37% share in 2025.

What factors are driving growth in the Blood Management Software Market?

Growth is driven by digitization of end-to-end blood workflows, stronger transfusion safety and traceability requirements, rising need for inventory optimization, and increased adoption of analytics-enabled decision support in blood operations.

Who are the major companies operating in the Blood Management Software Market?

Key companies include Veradigm, WellSky, Haemonetics, Oracle (Integrating Cerner Corporation), Epic Systems, Soft Computer Consultants (SCC Soft Computer), MAK-System, McKesson, Sunquest Information Systems, Mediware Information Systems, CompuGroup Medical, IT Synergistics, Hemosoft, and Sigma Blood Systems.

Which region leads the Blood Management Software Market?

North America leads the market, holding 38.10% share in 2025.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Blood Lancet Market

The global Blood Lancet Market size was estimated at USD 1,928.94 million in 2025 and is expected to reach USD 3,185.66 million by 2032, growing at a CAGR of 7.43% from 2025 to 2032.

Arteriovenous Fistula Devices Market

The Arteriovenous Fistula Devices Market is projected to grow from USD 379.23 million in 2024 to an estimated USD 671.33 million by 2032, with a CAGR of 7.40% from 2024 to 2032.

Arthroscopy Devices Market

The Arthroscopy Devices Market is projected to grow from USD 1673.66 million in 2024 to an estimated USD 2553 million by 2032, with a compound annual growth rate (CAGR) of 5.40% from 2024 to 2032.

Aspiration And Biopsy Needle Market

The Aspiration and Biopsy Needle Market is projected to grow from USD 772.86 million in 2024 to an estimated USD 1241.14 million by 2032, with a compound annual growth rate (CAGR) of 6.1% from 2024 to 2032.

Angio Suites Market

The Angio Suites Market is projected to grow from USD 2,322.1 million in 2024 to an estimated USD 3,577.23 million by 2032, with a CAGR of 5.6% from 2024 to 2032.

Wound Care Market

The Wound Care Market size was valued at USD 24,710 million in 2024 and is anticipated to reach USD 34,077.66 million by 2032, at a CAGR of 4.1% during the forecast period.

Surgical Helmet System Market

The Surgical Helmet System market size was valued at USD 71.00 million in 2024 and is anticipated to reach USD 100.26 million by 2032, at a CAGR of 4.46% during the forecast period.

Portable Oxygen Concentrators Market

The Portable Oxygen Concentrators market size was valued at USD 890.00 million in 2018, reached USD 1,237.19 million in 2024, and is anticipated to reach USD 2,694.15 million by 2032, growing at a CAGR of 10.31% during the forecast period.

Acoustic Medicine and Ultrasound Therapy Market

The Acoustic Medicine and Ultrasound Therapy Market is projected to grow from USD 1,487.5 million in 2025 to an estimated USD 2,599.3 million by 2032, registering a CAGR of 8.30% from 2025 to 2032.

Ablation Devices Market

The Ablation Device Market is projected to grow from USD 10,827.5 million in 2025 to an estimated USD 20,229.34 million by 2032, with a compound annual growth rate (CAGR) of 9.30% from 2025 to 2032.

Microdermabrasion Devices Market

The Global Microdermabrasion Devices Market size was valued at USD 430.00 million in 2018 to USD 582.73 million in 2024 and is anticipated to reach USD 1,111.50 million by 2032, at a CAGR of 8.48% during the forecast period.

Peripheral Vascular Stents Market

The Peripheral Vascular Stents Market size was valued at USD 1,450.00 million in 2018, increased to USD 1,915.31 million in 2024, and is anticipated to reach USD 3,546.81 million by 2032, at a CAGR of 8.12% during the forecast period.

Licence Option

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Europe

North America

Email

Smallform of Sample request
User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

cr-clients-logos

Request Sample